Visualization and dynamics of multidimensional health-related quality-of-life-adjusted overall survival: a new analytic approach.
Background: Vesnarinone Trial (VesT) was a three-armed, placebo-controlled, randomized clinical trial designed to study the effects of 30 mg or 60 mg/day vesnarinone. Certain contradictory results involving patient health-related quality-of-life (HRQOL) and overall survival (OS) have made a definiti...
| Publicado en: | Quality of Life Research Vol. 23; no. 5; pp. 1411 - 1420 |
|---|---|
| Autores principales: | , |
| Formato: | research randomized controlled trial Journal Article |
| Publicado: |
Springer Nature
Jun2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |